Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
ATH Technologies (E)
Simons, Robert L.; Packard, JenniferCaso HBS-117017-EDirección estratégicaSupplements the (A) case. Designed as an in-class handout.Desde 5,74 €
-
Merck: Managing Vioxx (E)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCaso HBS-109084-EDesde 5,74 €
-
ATH Technologies (E) (Spanish version)
Simons, Robert L.; Packard, JenniferCaso HBS-118S07Dirección estratégicaSupplements the (A) case. Designed as an in-class handout.Desde 5,74 €
-
Merck: La administración de Vioxx (E)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCaso HBS-111S06Conocimiento y comunicaciónDesde 5,74 €
-
Danone: Changing the Food System
Bell, David E.; Gabrieli, Federica; Beyersdorfer, DanielaCaso HBS-520053-EMarketingEmmanuel Faber, Chairman and CEO of the food and beverage company Danone, believed that humankind had only ten years to bend the curve on climate change and restore the biodiversity that the global food and agricultural ecosystem was critically dependent on. Upon becoming CEO in 2014, he had built on Danone's long history of CSR-engagement to give a boost to the company's mission to bring health through food to as many people as possible. In Sept...Desde 8,20 €
-
La Ribera Health Department (A)
Herzlinger, Regina E.; Moloney, Emer; Beyersdorfer, DanielaCaso HBS-315006-EEconomíaWhat Business Model elements enabled La Ribera to achieve this level of value? How can it improve on its 1% profit margin and better align itself with the Six Factors? The hospital hired a consulting firm that presented four new options that could potentially increase returns. Which, if any, best fit with the ten elements of its Business Model? The B case (9-318-134) contains the d nouement for La Ribera.Desde 8,20 €
-
L'Occitane en Provence
Becker, Bo; Beyersdorfer, Daniela; Mayfield, E. Scott; Yamazaki, MayukaCaso HBS-212051-EFinanzasCosmetics company L'Occitane en Provence must decide if it is the right time to go public, and, if so, where to list. The firm could list on Euronext in Paris, close to the firm's headquarters in southern France, on one of the large exchanges in the United States, or perhaps in Asia, where much of the firm's future growth is expected. The case provides opportunities to discuss the benefits and costs of going public, including valuation implicatio...Desde 8,20 €
-
C3.ai-Driven to Succeed
Simons, Robert L.; Gonzalez, GeorgeCaso HBS-119004-EDirección estratégicaCEO Tom Siebel navigates his artificial intelligence (ai) startup through a series of pivots, market expansions, and even an elephant attack to become a leading platform ad service provider. The case describes his unusual management approach emphasizing eDesde 8,20 €
-
The IASB at a Crossroads: The Future of International Financial Reporting Standards B
Ramanna, Karthik; Misztal, Karol; Beyersdorfer, DanielaCaso HBS-113089-EContabilidad y controlSupplement for case 111084. In late 2012, IASB chair Hans Hoogervorst, just over a year into his term, must address several serious geopolitical challenges that can derail IFRS growth. The SEC has issued a report outlining why the U.S. should not adopt IFRS. Other major economies such as Japan and India begin to dither on IFRS as well. The E--the IASB's main backers--is embroiled in a debt crisis that divides it; Britain--the strongest voice for ...Desde 8,20 €
-
Managing Vioxx (A) (Spanish version)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCaso HBS-111S02Dirección estratégica(B) evidence of life-threatening side effects, (C) decision options, (D) announcement to withdraw Vioxx, (E) reaction by patients, shareholders, media, and regulators, (F) Merck fights back, and (G) wrap-up. At the end of the case series, students may conclude that doing the right thing sometimes requires very hard choices.Desde 8,20 €